Clinical Trial

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

Study acronym: (TMS-EEG)
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-29; most recent amendment 2026-06-24.
Trial Details
NCT Number NCT06963775
Lead Sponsor Ramon Diaz-Arrastia
Collaborators: QuantalX Neuroscience
Conditions Traumatic Brain Injury
Enrollment 215 participants
Start Date 2026-07-15
Primary Completion 2030-03-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25